Log in

LON:ABCAbcam Share Price, Forecast & News

GBX 1,414
-11.00 (-0.77 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
1,412
Now: GBX 1,414
1,442
50-Day Range
1,119
MA: GBX 1,344.06
1,530
52-Week Range
943
Now: GBX 1,414
1,584
Volume269,772 shs
Average Volume497,233 shs
Market Capitalization£3.06 billion
P/E Ratio64.86
Dividend Yield0.85%
BetaN/A
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Read More
Abcam logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 1.3Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1223-696000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£259.90 million
Cash FlowGBX 42.40 per share
Book ValueGBX 187.50 per share

Profitability

Miscellaneous

Employees1,100
Market Cap£3.06 billion
Next Earnings DateN/A
OptionableOptionable

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

Abcam (LON:ABC) Frequently Asked Questions

How has Abcam's stock been impacted by COVID-19 (Coronavirus)?

Abcam's stock was trading at GBX 1,140 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 24.0% and is now trading at GBX 1,414. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Abcam?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Abcam.

How often does Abcam pay dividends? What is the dividend yield for Abcam?

Abcam announced a dividend on Monday, March 9th. Stockholders of record on Thursday, March 19th will be paid a dividend of GBX 3.55 per share on Friday, April 17th. This represents a yield of 0.31%. The ex-dividend date is Thursday, March 19th. The official announcement can be seen at this link. View Abcam's dividend history.

What price target have analysts set for ABC?

6 equities research analysts have issued 1 year price targets for Abcam's stock. Their forecasts range from GBX 1,188 to GBX 1,450. On average, they anticipate Abcam's share price to reach GBX 1,273.60 in the next twelve months. This suggests that the stock has a possible downside of 9.9%. View analysts' price targets for Abcam.

Has Abcam been receiving favorable news coverage?

Headlines about ABC stock have trended negative on Saturday, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Abcam earned a coverage optimism score of -2.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutAbcam.

Who are some of Abcam's key competitors?

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), HSBC (HSBA), Centrica (CNA) and Marks and Spencer Group (MKS).

Who are Abcam's key executives?

Abcam's management team includes the following people:
  • Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)
  • Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)
  • Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)
  • James Staveley, VP of Investor Relations
  • Mr. Nick Skinner, Sr. VP of HR

What is Abcam's stock symbol?

Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."

How do I buy shares of Abcam?

Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Abcam's stock price today?

One share of ABC stock can currently be purchased for approximately GBX 1,414.

How big of a company is Abcam?

Abcam has a market capitalization of £3.06 billion and generates £259.90 million in revenue each year. Abcam employs 1,100 workers across the globe.

What is Abcam's official website?

The official website for Abcam is www.abcam.com.

How can I contact Abcam?

Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.